JP2007532564A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532564A5
JP2007532564A5 JP2007507494A JP2007507494A JP2007532564A5 JP 2007532564 A5 JP2007532564 A5 JP 2007532564A5 JP 2007507494 A JP2007507494 A JP 2007507494A JP 2007507494 A JP2007507494 A JP 2007507494A JP 2007532564 A5 JP2007532564 A5 JP 2007532564A5
Authority
JP
Japan
Prior art keywords
formula
compound
substituted
alkyl
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007507494A
Other languages
English (en)
Japanese (ja)
Other versions
JP4869221B2 (ja
JP2007532564A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/011757 external-priority patent/WO2005100346A1/en
Publication of JP2007532564A publication Critical patent/JP2007532564A/ja
Publication of JP2007532564A5 publication Critical patent/JP2007532564A5/ja
Application granted granted Critical
Publication of JP4869221B2 publication Critical patent/JP4869221B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007507494A 2004-04-08 2005-04-07 プロゲステロン受容体調節剤としてのチオアミド誘導体 Expired - Fee Related JP4869221B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56056904P 2004-04-08 2004-04-08
US60/560,569 2004-04-08
PCT/US2005/011757 WO2005100346A1 (en) 2004-04-08 2005-04-07 Thioamide derivatives as progesterone receptor modulators

Publications (3)

Publication Number Publication Date
JP2007532564A JP2007532564A (ja) 2007-11-15
JP2007532564A5 true JP2007532564A5 (enExample) 2008-04-10
JP4869221B2 JP4869221B2 (ja) 2012-02-08

Family

ID=34965700

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007507494A Expired - Fee Related JP4869221B2 (ja) 2004-04-08 2005-04-07 プロゲステロン受容体調節剤としてのチオアミド誘導体

Country Status (14)

Country Link
US (4) US7358246B2 (enExample)
EP (1) EP1732921B1 (enExample)
JP (1) JP4869221B2 (enExample)
CN (1) CN100522960C (enExample)
AT (1) ATE413398T1 (enExample)
AU (1) AU2005233591B2 (enExample)
BR (1) BRPI0509209A (enExample)
CA (1) CA2561014C (enExample)
DE (1) DE602005010840D1 (enExample)
DK (1) DK1732921T3 (enExample)
ES (1) ES2317223T3 (enExample)
MX (1) MXPA06011696A (enExample)
PL (1) PL1732921T3 (enExample)
WO (1) WO2005100346A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE409699T1 (de) * 2004-04-08 2008-10-15 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
CA2561014C (en) * 2004-04-08 2013-09-10 Wyeth Thioamide derivatives as progesterone receptor modulators
GT200500185A (es) * 2004-08-09 2006-04-10 Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
US20070093548A1 (en) * 2005-10-25 2007-04-26 Wyeth Use of progesterone receptor modulators
US7618989B2 (en) * 2006-08-15 2009-11-17 Wyeth Tricyclic oxazolidone derivatives useful as PR modulators
EA201070715A1 (ru) * 2007-12-20 2011-02-28 Тева Вимен'С Хелс, Инк. Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
CN107281215A (zh) * 2016-04-01 2017-10-24 复旦大学附属妇产科医院 硫化氢供体硫氢化钠在制药中的用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4295987A (en) * 1979-12-26 1981-10-20 The Procter & Gamble Company Cross-linked sodium polyacrylate absorbent
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
AU608891B2 (en) 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US5273752A (en) * 1989-07-18 1993-12-28 Alza Corporation Controlled release dispenser comprising beneficial agent
US5124455A (en) * 1990-08-08 1992-06-23 American Home Products Corporation Oxime-carbamates and oxime-carbonates as bronchodilators and anti-inflammatory agents
US5459151A (en) * 1993-04-30 1995-10-17 American Home Products Corporation N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents
US5854388A (en) * 1993-06-24 1998-12-29 Washington State University Research Foundation Angiotensin IV peptides and receptor
US5817343A (en) * 1996-05-14 1998-10-06 Alkermes, Inc. Method for fabricating polymer-based controlled-release devices
US5756127A (en) * 1996-10-29 1998-05-26 Wright Medical Technology, Inc. Implantable bioresorbable string of calcium sulfate beads
FI971385A0 (fi) 1997-04-04 1997-04-04 Bioxid Oy Biokompatibel komposition, metoder foer dess framstaellning samt anvaendning daerav
US6391907B1 (en) * 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6417214B1 (en) * 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6509334B1 (en) * 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
BR0010216A (pt) * 1999-05-04 2002-03-19 American Home Prod Derivados de tio-oxindol
HUP0203332A3 (en) * 1999-05-04 2004-12-28 Wyeth Corp Cyclothiocarbamate derivatives, their use as progesterone receptor modulators and pharmaceutical compositions containing them
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
EP1202955A4 (en) * 1999-08-10 2004-02-11 Smithkline Beecham Corp 1,4-SUBSTITUTED 4,4-DIARYLCYCLOHEXANES
US6258833B1 (en) * 1999-12-23 2001-07-10 Icos Corporation Cyclic AMP-specific phosphodiesterase inhibitors
UA73119C2 (en) * 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP4716547B2 (ja) * 2000-08-10 2011-07-06 住友精化株式会社 ２−フェニルチアゾール類の製造方法
US20030225273A1 (en) * 2002-03-21 2003-12-04 Michaelides Michael R. Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
US20060100199A1 (en) 2002-06-06 2006-05-11 Seiji Yoshikawa Novel condensed imidazole derivatives
TW200407124A (en) * 2002-06-25 2004-05-16 Wyeth Corp Use of thio-oxindole derivatives in treatment of hormone-related conditions
RU2005101624A (ru) * 2002-06-25 2005-06-27 Уайт (Us) Применение производных тиооксиндола в терапии кожных нарушений
CN1665510A (zh) * 2002-06-25 2005-09-07 惠氏公司 作为pr调节剂的环硫代氨基甲酸酯衍生物的衍生物和其用于治疗皮肤病的用途
CN1662241A (zh) * 2002-06-25 2005-08-31 惠氏公司 环硫代氨基甲酸酯衍生物在治疗与激素有关的病症中的用途
CA2561014C (en) * 2004-04-08 2013-09-10 Wyeth Thioamide derivatives as progesterone receptor modulators
BRPI0509159B1 (pt) 2004-04-08 2014-08-26 Wyeth Llc Processo para preparar um composto de fenoxicicloalquila
ATE409699T1 (de) 2004-04-08 2008-10-15 Wyeth Corp Verfahren zur minimierung von thioamidverunreinigungen
CA2563063C (en) 2004-04-27 2014-06-03 Wyeth Purification of progesterone receptor modulators

Similar Documents

Publication Publication Date Title
CN1133635C (zh) 用于结合黄体酮受体的氰基吡咯类
TWI373470B (en) Process for preparing amino crotonyl compounds
JP5599236B2 (ja) 化学療法薬および化学防御薬としてのインドール−３−カルビノール代謝物の類似物
CN102066323B (zh) 新的雌激素受体配体
JP2015523365A5 (enExample)
CN104428309B (zh) 3-取代的雌甾-1,3,5(10),16-四烯衍生物、其制备方法、包含其的药物制剂及其用于制备药物的用途
MX2007001614A (es) Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y usos de los mismos.
BR112015018882B1 (pt) Derivados de benzotiofeno e composições dos mesmos como degradadores de receptor de estrogênio seletivo
WO2000066574A1 (en) 2,1-benzisothiazoline 2,2-dioxides
JP2007505164A5 (enExample)
CN102753565A (zh) 孕酮受体拮抗剂
CN101970436A (zh) 用于治疗中枢神经系统功能障碍的氮杂吲哚化合物
CN102596985B (zh) 17‑羟基‑17‑五氟乙基‑雌‑4，9(10)‑二烯‑11‑芳基衍生物、其制备方法及其用于治疗疾病的用途
WO2006116526A8 (en) Polymorph form ii of tanaproget
CN103145617A (zh) 菲啶类衍生物及其药物组合物和其制备方法与应用
CN1062528A (zh) 苯并二氮杂酮
HU201920B (en) Process for producing 3-aminodihydro-(1)-benzopyran derivatives and pharmaceutical compositions comprising same
KR100292928B1 (ko) 치환된헥사하이드로벤조페난트리딘
CN1906206A (zh) 雌二醇的二－甾族前体药物
CN1635889A (zh) 异噁唑并吡啶酮类化合物及其在治疗帕金森氏病中的用途
CZ70594A3 (en) Thiadiazinones
CA2490002A1 (en) Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
ES2349325T3 (es) Moduladores del receptor de progesterona de piridooxazepina.
TW200817370A (en) Process for the preparation of indolin-2-one derivatives useful as pr modulators
JP2007532564A (ja) プロゲステロン受容体調節剤としてのチオアミド誘導体